Literature DB >> 15814688

Translation from cryptic reading frames of DNA vaccines generates an extended repertoire of immunogenic, MHC class I-restricted epitopes.

Reinhold Schirmbeck1, Petra Riedl, Nicolas Fissolo, Francois A Lemonnier, Antonio Bertoletti, Jörg Reimann.   

Abstract

To test whether simple expression units used in DNA vaccines can generate immunogenic, MHC class I-binding epitopes by translating other than the primary open reading frame (ORF), we constructed a vector (pCI/SX) that encodes the small hepatitis B surface Ag in the primary ORF, and a C-terminal fragment (residue 344-832) of the polymerase (Pol) in an alternative (out-of-frame) reading frame. pCI/SX efficiently primed multispecific, HLA-A2-restricted CD8+ T cell responses to epitopes of hepatitis B surface Ag and of Pol (Pol3, Pol(803-811)). Pol3-containing products generated from pCI/SX were detected only by T cell assays, but not by biochemical assays. Priming Pol-specific T cell responses to epitopes generated from alternative ORFs depended on promoter sequences that drive transcription in the DNA vaccine (human CMV-derived promoter sequences being more efficient than SV40-derived promoter sequences). Human CMV promoter-driven Pol constructs encoding different Pol fragments in primary or alternative reading frames elicited comparable levels of Pol3-specific T cell responses. We confirmed efficient T cell priming to epitopes from alternative ORFs by constructing DNA vaccines that encode an SV40-derived cT(1-272) protein fused either in frame or out of frame with an immunogenic OVA fragment (OVA(18-385)). Similar OVA-specific CD8+ T cell responses were primed by both alternative vaccine constructs. Hence, DNA vaccine-stimulated T cell responses to epitopes generated from alternative ORFs seem to be a regular event, although its biological role and risks are largely unexplored.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15814688     DOI: 10.4049/jimmunol.174.8.4647

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  CX3CR1⁺ cells facilitate the activation of CD4 T cells in the colonic lamina propria during antigen-driven colitis.

Authors:  V Rossini; D Zhurina; K Radulovic; C Manta; P Walther; C U Riedel; J H Niess
Journal:  Mucosal Immunol       Date:  2013-10-16       Impact factor: 7.313

2.  Characterization of T-cell responses to cryptic epitopes in recipients of a noncodon-optimized HIV-1 vaccine.

Authors:  Anne Bet; Sarah Sterrett; Alicia Sato; Anju Bansal; Paul A Goepfert
Journal:  J Acquir Immune Defic Syndr       Date:  2014-02-01       Impact factor: 3.731

Review 3.  Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.

Authors:  James A Williams; Aaron E Carnes; Clague P Hodgson
Journal:  Biotechnol Adv       Date:  2009-02-20       Impact factor: 14.227

4.  Enhanced Recognition of HIV-1 Cryptic Epitopes Restricted by HLA Class I Alleles Associated With a Favorable Clinical Outcome.

Authors:  Anju Bansal; Tiffanie Mann; Sarah Sterrett; Binghao J Peng; Anne Bet; Jonathan M Carlson; Paul A Goepfert
Journal:  J Acquir Immune Defic Syndr       Date:  2015-09-01       Impact factor: 3.731

5.  Transcriptional errors in human immunodeficiency virus type 1 generate targets for T-cell responses.

Authors:  Keith E Garrison; Stephane Champiat; Vanessa A York; Ashish T Agrawal; Esper G Kallas; Jeffrey N Martin; Frederick M Hecht; Steven G Deeks; Douglas F Nixon
Journal:  Clin Vaccine Immunol       Date:  2009-07-01

6.  Defining the mechanism(s) of protection by cytolytic CD8 T cells against a cryptic epitope derived from a retroviral alternative reading frame.

Authors:  Melanie R Rutkowski; On Ho; William R Green
Journal:  Virology       Date:  2009-06-18       Impact factor: 3.616

7.  Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells.

Authors:  Valerio Rossini; Katarina Radulovic; Christian U Riedel; Jan Hendrik Niess
Journal:  J Vis Exp       Date:  2016-09-18       Impact factor: 1.355

8.  Cellular immune response to cryptic epitopes during therapeutic gene transfer.

Authors:  Chengwen Li; Kevin Goudy; Matt Hirsch; Aravind Asokan; Yun Fan; Jeff Alexander; Junjiang Sun; Paul Monahan; David Seiber; John Sidney; Alessandro Sette; Roland Tisch; Jeff Frelinger; R Jude Samulski
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-16       Impact factor: 11.205

Review 9.  Non-conventional sources of peptides presented by MHC class I.

Authors:  Shelley R Starck; Nilabh Shastri
Journal:  Cell Mol Life Sci       Date:  2011-03-10       Impact factor: 9.261

10.  Strict control of transgene expression in a mouse model for sensitive biological applications based on RMCE compatible ES cells.

Authors:  U Sandhu; M Cebula; S Behme; P Riemer; C Wodarczyk; D Metzger; J Reimann; R Schirmbeck; H Hauser; D Wirth
Journal:  Nucleic Acids Res       Date:  2010-10-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.